Trial result ·
A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study tested a set of drugs given before a stem cell transplant. It was done in people with severe aplastic anemia. The drugs were fludarabine, cyclophosphamide and porcine anti-lymphocyte globulin. The trial took in 48 people. Each person got stem cells from a brother or sister with a close tissue type. All people got the same drugs, so there was no comparison group.
What they found
In all people, new white blood cells grew from the donor cells. This took a median of 12 days. Nearly all people also had their platelet counts come back. That took a median of 13 days. By day 30, donor cells had fully taken over in nearly all people. Some people had heart side effects. No grade 4 harms from the drugs were seen. Some people got graft-versus-host disease, where donor cells attack the body. Nearly all people were alive at 1 year.
What it means for patients
The authors say this drug mix was linked to stable growth of donor cells. They judged its safety to be acceptable. They also said the rate of graft-versus-host disease was manageable.
Why it is not certain yet
All 48 people got the same treatment. With no comparison group, it is hard to judge it against other drug mixes. The abstract reports survival at 1 year only. It does not give longer-term results. All donors were brothers or sisters with a close tissue type.
Source
A prospective, open, single-arm clinical trial of fludarabine- cyclophosphamide-porcine anti-lymphocyte globulin conditioning combined with matched sibling donor hematopoietic stem cell transplantation in the treatment of severe aplastic anemia.
PubMed · PMID 42118371We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Aplastic anaemia publications